(EUA) to permit the emergency use of the unapproved product sotrovimab for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults ...

Sotrovimab (Xevudy) ... Sotrovimab is a medicine used to treat COVID-19 (coronavirus). It's available to people who are at the highest risk of serious illness or ...

... bør ikke benyttes med mindre det er overveiende sannsynlig at pasienten er smittet av en variant av SARS-CoV-2 som sotrovimab har antatt effekt mot ...

8. apr. 2022 ... The Panel previously recommended the anti-SARS-CoV-2 mAb sotrovimab as a treatment option for certain nonhospitalized patients with COVID-19 ...

14. apr. 2022 ... Sotrovimab is a monoclonal antibody that is available under emergency use authorization for the treatment of patients who are at risk for ...

14. apr. 2022 ... (Nov. 18 issue) on the administration of the SARS-CoV-2 neutralizing antibody sotrovimab to prevent the progression of Covid-19. First, ...

Learn about sotrovimab, a COVID-29 monoclonal antibody therapeutic.

Medscape - Mild-to-moderate COVID-19 dosing for sotrovimab, frequency-based adverse effects, comprehensive interactions, contraindications, ...

Sotrovimab (sotrovimab for intravenøs infusjon). Preparatomtale. Mulige bivirkninger av et medikament må rapporteres. Helsepersonell kan melde mulige ...

28. mar. 2022 ... Xevudy contains the active substance sotrovimab. Sotrovimab is a monoclonal antibody, a type of protein designed to recognise a specific ...